Synapse - Works

Results (2899)

Chimeric antigen receptor T Cells: Clinical applications, advances and challenges

Book Section

O’Connor, M. H.; Madugula, K.; Smith, M.
In Jain, P.; Ndhlovu, L.C. (Eds.) Advanced Concepts in Human Immunology: Prospects for Disease Control (2020)

Fulltext@MSK | Save

Less can be more when targeting interleukin-6-mediated cytokine release syndrome in coronavirus disease 2019

Editorial

Betts, B. C.; Young, J. W.
Critical Care Explorations (2020)

Fulltext@MSK | Save

Case study—methotrexate toxicity, treatment, and measurement

Book Section

Bhatt, V.; Scordo, M.; Carlow, D. C.
In Ketha, H.; Garg, U. (Eds.) Toxicology Cases for the Clinical and Forensic Laboratory (2020)

Fulltext@MSK | Save

Duration of post-autologous hematopoietic cell transplant anemia and thrombocytopenia are associated with prolonged hospital length-of-stay for multiple myeloma patients

Meeting Abstract

Zheng-Lin, B.; Krishnamurthi, N.; Diamond, B.; Maclachlan, K. H.; Maura, F.; Landgren, O.; Chung, D. J.
Blood (2020)

Fulltext@MSK | Save

Superiority of thiotepa-containing conditioning regimens in patients with primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS) undergoing autologous hematopoietic cell transplantation (autoHCT)

Meeting Abstract

Wang, T.; Scordo, M.; Ahn, K. W.; Chen, S.; Kharfan-Dabaja, M. A.; Herrera, A. F.; Hamadani, M.; Sauter, C. S.
Blood (2020)

Fulltext@MSK | Save

VRd versus KRd safety profiles in newly diagnosed multiple myeloma patients using real-world evidence data from a single institution: VRd has high rates of chronic neuropathy, and KRd has low rates of cardiopulmonary or renal toxicities when using optimized IV fluid management coupled with baseline cardiac workup

Meeting Abstract

Tan, C.; Diamond, B.; Hultcrantz, M.; Korde, N.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; Lu, S. X.; Patel, D.; more...
Blood (2020)

Fulltext@MSK | Save

Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy

Meeting Abstract

Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
Blood (2020)

Fulltext@MSK | Save

Maintenance use is more important than the choice of bortezomib-based triplet induction in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation

Meeting Abstract

Sidana, S.; Kumar, S. K.; Fraser, R.; Estrada-Merly, N.; Norkin, M.; Giralt, S.; Qazilbash, M. H.; Shah, N.; D'Souza, A.
Blood (2020)

Fulltext@MSK | Save

Bridging the gap in access to transplant for underserved minority patients using mismatched unrelated donors and post-transplant cyclophosphamide: A National Marrow Donor Program/Be The Match (NMDP/BTM) Initiative

Meeting Abstract

Shaw, B. E.; Jimenez-Jimenez, A.; Burns, L. J.; Logan, B.; Khimani, F.; Shaffer, B. C.; Shah, N. N.; Mussetter, A.; Tang, X. Y.; McCarty, J. M.; more...
Blood (2020)

Fulltext@MSK | Save

Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia

Meeting Abstract

Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
Blood (2020)

Fulltext@MSK | Save